Page last updated: 2024-09-03

fosamprenavir and zolpidem

fosamprenavir has been researched along with zolpidem in 1 studies

Compound Research Comparison

Studies
(fosamprenavir)
Trials
(fosamprenavir)
Recent Studies (post-2010)
(fosamprenavir)
Studies
(zolpidem)
Trials
(zolpidem)
Recent Studies (post-2010) (zolpidem)
17455371,825368683

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)zolpidem (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.048
Translocator proteinRattus norvegicus (Norway rat)4.7
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.048
GABA theta subunitRattus norvegicus (Norway rat)0.048
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for fosamprenavir and zolpidem

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016